|Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study|
FE Dewey, MF Murray, JD Overton, L Habegger, JB Leader, SN Fetterolf, ...
Science 354 (6319), 2016
|A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease|
NS Abul-Husn, X Cheng, AH Li, Y Xin, C Schurmann, P Stevis, Y Liu, ...
New England Journal of Medicine 378 (12), 1096-1106, 2018
|Genetic identification of familial hypercholesterolemia within a single US health care system|
NS Abul-Husn, K Manickam, LK Jones, EA Wright, DN Hartzel, ...
Science 354 (6319), 2016
|Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats|
KJ Powell, NS Abul-Husn, A Jhamandas, MC Olmstead, RJ Beninger, ...
Journal of Pharmacology and Experimental Therapeutics 300 (2), 588-596, 2002
|Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records|
SL Van Driest, QS Wells, S Stallings, WS Bush, A Gordon, DA Nickerson, ...
Jama 315 (1), 47-57, 2016
|Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins|
JA Morón, NS Abul-Husn, R Rozenfeld, G Dolios, R Wang, LA Devi
Molecular & Cellular Proteomics 6 (1), 29-42, 2007
|Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants|
K Manickam, AH Buchanan, MLB Schwartz, MLG Hallquist, JL Williams, ...
JAMA Network Open 1 (5), e182140-e182140, 2018
|Implementation and utilization of genetic testing in personalized medicine|
NS Abul-Husn, AO Obeng, SC Sanderson, O Gottesman, SA Scott
Pharmacogenomics and personalized medicine 7, 227, 2014
|Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of μ‐ and δ‐opioid receptor antagonists|
NS Abul‐Husn, M Sutak, B Milne, K Jhamandas
British journal of pharmacology 151 (6), 877-887, 2007
|Personalized medicine and the power of electronic health records|
NS Abul-Husn, EE Kenny
Cell 177 (1), 58-69, 2019
|An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function|
R Rozenfeld, NS Abul-Husn, I Gomez, LA Devi
TheScientificWorldJOURNAL 7, 64-73, 2007
|Systems approach to explore components and interactions in the presynapse|
NS Abul‐Husn, I Bushlin, JA Morón, SL Jenkins, G Dolios, R Wang, ...
Proteomics 9 (12), 3303-3315, 2009
|Chronic morphine alters the presynaptic protein profile: identification of novel molecular targets using proteomics and network analysis|
NS Abul-Husn, SP Annangudi, A Ma'Ayan, DL Ramos-Ortolaza, ...
PloS one 6 (10), e25535, 2011
|Genetic identification of a common collagen disease in puerto ricans via identity-by-descent mapping in a health system|
GM Belbin, J Odgis, EP Sorokin, MC Yee, S Kohli, BS Glicksberg, ...
Elife 6, e25060, 2017
|Neuroproteomics of the synapse and drug addiction|
NS Abul-Husn, LA Devi
Journal of Pharmacology and Experimental Therapeutics 318 (2), 461-468, 2006
|Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or Hispanic/Latino ancestry|
SM Damrauer, K Chaudhary, JH Cho, LW Liang, E Argulian, L Chan, ...
Jama 322 (22), 2191-2202, 2019
|Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants|
AH Buchanan, K Manickam, MN Meyer, JK Wagner, MLG Hallquist, ...
Genetics in Medicine 20 (5), 554-558, 2018
|Physician attitudes toward adopting genome-guided prescribing through clinical decision support|
CL Overby, AL Erwin, NS Abul-Husn, SB Ellis, SA Scott, AO Obeng, ...
Journal of personalized medicine 4 (1), 35-49, 2014
|COVID-19 outcomes and the human genome|
MF Murray, EE Kenny, MD Ritchie, DJ Rader, AE Bale, MA Giovanni, ...
Genetics in Medicine 22 (7), 1175-1177, 2020
|SNAVI: Desktop application for analysis and visualization of large-scale signaling networks|
A Ma'ayan, SL Jenkins, RL Webb, SI Berger, SP Purushothaman, ...
BMC systems biology 3 (1), 1-11, 2009